Clinical Roundup Researchers from Wistar and ChristianaCare identify therapeutic target for pancreatic cancer May 01, 2026Vol.52 No.17
Clinical Roundup 65% of eligible lung cancer patients do not receive the most appropriate targeted therapies May 01, 2026Vol.52 No.17
Clinical Roundup “Forever chemicals” may be linked to childhood leukemia, UC Irvine study finds May 01, 2026Vol.52 No.17
Clinical Roundup Eating primes immune cells for future responses, UPMC study finds May 01, 2026Vol.52 No.17
Clinical Roundup CAR T-cell therapy for high-risk smoldering MM shows deep and lasting responses in phase II study April 24, 2026Vol.52 No.16
Clinical Roundup Johns Hopkins-led study shows how bacterial toxin drives colon tumor formation April 24, 2026Vol.52 No.16
Clinical Roundup ATOMIC phase III trial establishes standard-of-care for patients with stage 3 dMMR colon cancer April 17, 2026Vol.52 No.15
Clinical Roundup Experimental drug doubles one-year survival in pancreatic cancer trial, Northwestern study finds April 17, 2026Vol.52 No.15
Clinical Roundup First in-human trial primes immune system to accept donor livers, UPMC study finds April 17, 2026Vol.52 No.15
Clinical Roundup DYV800 topical therapy targets tumor acidity, preclinical study finds April 17, 2026Vol.52 No.15
